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Abstract 
Kisspeptins, endogenous peptide ligands for GPR54, play an important role in GnRH secretion. 
Since in vivo administration of kisspeptins induces increased plasma LH levels, GPR54 agonists 
hold promise as therapeutic agents for the treatment of hormonal secretion diseases. To facilitate the 
design of novel potent GPR54 ligands, residues in kisspeptins that involve in the interaction with 
GPR54 were investigated by kisspeptin-based photoaffinity probes. Herein, we report the design 
and synthesis of novel kisspeptin-based photoaffinity probes, and the application to crosslinking 
experiments for GPR54-expressing cells. 
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Abbreviations: GPR54, G-protein coupled receptor 54; Kp-54, kisspeptin-54; Kp-14, kisspeptin-14, 
Kp-13, kisspeptin-13, Kp-10, kisspeptin-10; GnRH, gonadotropin-releasing hormone; NPFFRs, 
neuropeptide FF receptors; PEG, polyethylene glycol; Fmoc-SPPS, Fmoc-based solid phase peptide 
synthesis; HRP, horseradish peroxidase. 
Kisspeptins, proteolytic products of the propeptide encoded by the Kiss1 gene, have been 
identified as an endogenous ligand of G protein-coupled receptor 54 (GPR54).1-5 Full-length 
54-residue kisspeptin (Kp-54) and endogenous short peptides [kisspeptin-14 (Kp-14) and 
kisspeptin-13 (Kp-13)] share the C-terminal consensus sequence of the RF-amide peptide family, 
-Arg-Phe-NH2.1 The kisspeptin-GPR54 signaling complex plays a vital role in gonadotropin 
secretion via stimulation of gonadotropin-releasing hormone (GnRH) release.6-16 The in vivo 
administration of kisspeptins and derivatives with potent GPR54 agonistic activity induces an 
increase in the plasma LH level.17,18 Thus, GPR54 agonists are expected to be potential 
pharmaceutical agents for disorders of hormone secretion. 
In 2001, Ohtaki et al. reported that the C-terminal 10-residue peptide [kisspeptin-10 (Kp-10)] was 
the minimal bioactive sequence of kisspeptins. Although Kp-10 has been reported to exert 
antimetastatic effects via GPR54 activation,4,19 Kp-10 was found to be rapid degraded in serum.20 
Recently, several biostable Kp-10 analogs have been developed.20-23 For example, TAK-488 with 
good peptidase resistance retains highly potent GPR54 agonistic activity that is comparable to 
Kp-10.22 We have also identified a pentapeptide-based GPR54 agonist, FTM080, through 
down-sizing studies of Kp-10.24,25 Further structure-activity relationship studies of FTM080 using a 
series of peptidomimetics identified FTM145 with high biological stabilities.26 
These previous studies demonstrated the requirement for the C-terminal region of kisspeptins in 
direct receptor binding and activation of GPR54. However, for the design of more potent GPR54 
ligands, elucidation of the contact residues in kisspeptins and the recognition modes for GPR54 are 
required. A positional scanning approach of kisspeptin-based photoaffinity probes was used to 
identify residues that interact with GPR54. Reported herein is the development and application of 
novel photoaffinity probes derived from two endogenous kisspeptins, Kp-54 and Kp-14. 
Initially, we designed Kp-54-based probes that contain a photoreactive group to form a covalent 
bond onto GPR54 and a biotin tag to detect labeled GPR54.27-29 Since the C-terminal region of 
kisspeptins is required for binding to GPR54,4,24-26 the biotin group was conjugated at the 
N-terminus of Kp-54. A panel of ligands was created with the photoreactive functional group 
conjugated to the Cys thiol group at the N-terminal Ser5, Ser10, Gln15, Ser20, Arg25, Pro30, Leu35, or 
Lys40 locations with Cys replacements (designated S5C, S10C, Q15C, S20C, R25C, P30C, L35C, 
or K40C, respectively) (Fig. 1). Each residue in the C-terminal sequence, Tyr45-Leu52, was also 
modified with the photoreactive group (designated Y45C, N46C, W47C, N48C, S49C, F50C, G51C, 
and L52C). All the probes retained the indispensable C-terminal RF-amide substructure 
(-Arg53-Phe54-NH2). 
Peptide chains of Kp-54 derivatives were constructed by standard Fmoc-based solid-phase 
peptide synthesis (Fmoc-SPPS) on Novasyn® TGR resin. The amino acid at the modification site 
for a photoreactive functional group was substituted with a Cys residue. The N-terminal biotin was 
attached by the standard coupling protocol. After final deprotection and cleavage from the resin, the 
photoreactive group-conjugated maleimide 1 was attached onto the Cys thiol group in the 
biotinylated Kp-54 peptides. RP-HPLC purification afforded the expected Kp-54 peptides, which 
were identified with ESI-MS (Table S1). 
Using this panel of Kp-54-based probes, the crosslinking experiment was carried out for HEK293 
cells stably expressing GPR54. After incubation with the probes, the cells were exposed to UV light 
through a 300 nm long pass filter for 30 s. The cell lysates were separated by SDS-PAGE and the 
biotin on the kisspeptin crosslinked to GPR54 was subsequently detected by probing Western blots 
with horseradish peroxidase (HRP)-conjugated streptavidin. When using six probes (P30C, L35C, 
K40C, Y45C, N46C and W47C), a 65-kDa band was detected (Fig. 2A). In the competitive binding 
experiments of these six probes in the presence of unlabeled Kp-10, this 65-kDa band completely 
disappeared (Fig. 2B), indicating the specific detection of GPR54. Of note, the probes with 
modification at the N-terminus (S5C, S10C, Q15C, S20C or R25C) did not form a covalent 
crosslink to GPR54, presumably because these residues are not located in sufficiently close 
proximity to directly interact with  the receptor. In addition, when using the probes with 
modification at a C-terminal residue (N48C, S49C, F50C, G51C or L52C), crosslinks to GPR54 
were not observed. This is consistent with the findings from our previous alanine scanning 
experiments of Kp-10, in which substitution of these residues resulted in significant reductions in 
the agonistic activity.25 The modification of these residues with a photoaffinity functional group 
may interfere with crucial interactions necessary for binding to GPR54. Taken together, we have 
identified six Kp-54-based photoaffinity probes with modification of residues upstream of the 
C-terminal necessary residues for GPR54 binding, suggesting that this region (Pro30–Trp47) in 
Kp-54 may contribute to the secondary site(s) for binding to GPR54. 
We next used this approach for the development of photoaffinity probes using Kp-14. On the 
basis of the structure-activity relationships obtained by the Kp-54-based probe studies, we designed 
three photoaffinity probes with an N-terminal biotin and a photoreactive group at Tyr5, Asn6 or Trp7 
in Kp-14 (Fig. 1). These modified residues correspond to Tyr45, Asn46 and Trp47 in Kp-54, which 
were successfully modified with the photoreactive group in the functional Kp-54-based probes. 
However, contrary to our expectation, no labeling of GPR54 was observed using these probes (Fig. 
3A). We assumed that streptavidin binding to the probes in the Western blot analysis was inhibited 
because the biotin tag was attached directly to the bioactive Kp-14 sequence without any linker.30 
To avoid the possible reduced accessibility of streptavidin, three probes with a polyethylene 
glycol (PEG)27 linker between biotin and the Kp-14 sequence (Y5C, N6C and W7C) were designed 
and synthesized. Among these pegylated Kp-14-based probes, crosslinking of W7C to GPR54 was 
observed by Western blot analysis using HRP-conjugated streptavidin (Fig. 3A). The binding 
specificity of these Kp-14-derived probes for GPR54 was also confirmed by a competitive binding 
experiment with unlabeled Kp-10 (Fig. 3B). 
Hormonal secretions are regulated by multiple interactions between a number of 
neuropeptides/peptide hormones and receptors. Recently, we and others reported that short 
kisspeptin peptides such as Kp-14 and Kp-10 activate two neuropeptide FF receptors (NPFFRs: 
NPFFR1/GPR147 and NPFFR2/GPR74),31,32 which possibly function(s) as negative regulator(s) of 
GnRH secretion.33-35 Although the roles in reproductive physiology for the kisspeptin-NPFFR pairs 
have not been clearly defined, Kp-54 and the proteolytically processed short peptides may 
contribute to some physiological functions including GnRH release from the median eminence via 
an unknown interaction network(s).36-39 These Kp-14-based probes would be useful for the 
photoaffinity labeling experiments to identify previously unrecognized target(s) of kisspeptins.27-29 
It has been reported that the GPR54 protein (42.5 kDa) contains three N-linked glycosylation sites 
within the N-terminal region.3 To further rationalize the identification of GPR54 using Kp-54- and 
Kp-14-based photoaffinity probes, deglycosylation experiments of the crosslinked 65 kDa protein 
were carried out. After UV light exposure in the presence of W47C or W7C (500 nM) for 
photocrosslinking, the cell lysates were subjected to deglycosylation treatment using peptide 
N-glycosidase (PNGase F). SDS-PAGE separation followed by Western blot analysis demonstrated 
that the 65 kDa band was shifted to a mass indicative of a protein that had undergone removal of 
N-linked oligosaccharide chains (Fig. 4). This observation provides further evidence that the labeled 
protein with the probes was GPR54. 
In conclusion, we have designed and synthesized photoaffinity probes based on two endogenous 
kisspeptin sequences (Kp-54 and Kp-14). Six Kp-54-based probes (P30C, L35C, K40C, Y45C, 
N46C and W47C) and one Kp-14-based probe (W7C) clearly detected GPR54 on living cells in a 
specific manner, suggesting these residues constitute the secondary interactive sites of Kp-54 and 
Kp-14 for receptor binding to GPR54. These probes should be promising tools to identify the 
distributions of possible kisspeptin receptors, including GPR54. 
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Figure 1. Design of Kp-54- and Kp-14-based photoaffinity probes for GPR54 and the structure of 






Figure 2. Photocrosslinking experiment of GPR54 with Kp-54-based probes. (A) 
GPR54-expressing HEK293 cells were incubated with Kp-54-based photoaffinity probes, followed 
by UV irradiation. Biotin on the crosslinked GPR54 was detected by Western blot analysis. (B) 
GPR54-expressing HEK293 cells were exposed to a potential Kp-54-based probe (P30C, L35C, 
K40C, Y45C, N46C and W47C; 500 nM) in the presence (+) or absence (–) of unlabeled Kp-10 (10 
M) for the competitive experiments. 
 
 Figure 3. Photocrosslinking experiments of GPR54 with Kp-14-based probes. (A) 
GPR54-expressing HEK293 cells were labeled by Kp-14-based probes. Biotin on the crosslinked 
GPR54 was detected by Western blot analysis. (B) GPR54-expressing HEK293 cells were exposed 
to W7C (500nM) in the presence (+) or absence (–) of unlabeled Kp-10 (10 M) for the 





Figure 4. Deglycosylation experiments of labeled GPR54 by W47C (left) and W7C (right). After 
photocrosslinking, the cell lysate was incubated in the presence (+) or absence (–) of PNGase F. 
Biotin on the crosslinked GPR54 was detected by Western blot analysis. 
 
